Tag Archives: Centers for Disease Control and Prevention
The DxTerity COVID-19 Saliva at-Home Collection Kit detects the presence of the virus but does not confirm immunity or detect antibodies. DxTerity‘s molecular-based PCR test received approval from the Food and Drug Administration last month. The test differs from the quicker and less expensive antigen tests, which use a nasal swab or throat swab to detect the virus.
A single COVID-19 testing kit is listed for $110, and a 10-pack bundle is available for $1,000.
Test takers must spit into a tube provided by the kit. The saliva sample is then inserted into a plastic bag and packed back into the box for shipment to one of DxTerity‘s laboratories certified by the Clinical Laboratory Improvement Amendments. Customers are also granted prepaid express return shipping with the test and should expect to receive results within 24 to 72 hours of sample receipt at the laboratory. DxTerity’s test is currently the only COVID-19 testing kit on Amazon.
“We have demonstrated the reliability and quality of our COVID-19 testing solution with big business and now we want to expand access to customers at home and small businesses,” said Bob Terbrueggen, founder and CEO of DxTerity, when he first announced the collaboration with the company last month. “Amazon is the perfect partner for expanding access to millions of U.S. customers.”
The test may not be valid for all travel purposes because sample collection is unsupervised, according to the product description. The Centers for Disease Control and Prevention recommends saliva specimens should be collected under supervision.
Amazon joins other retail giants in offering at-home COVID-19 saliva tests. Costco offers both regular and those approved for travel requirements to Hawaii, Bermuda and some other destinations for $129.99 and $139.99, respectively. However, the test has several dozen one-star reviews, with most complaining about delayed shipping and poor customer service from provider AZOVA.
Just over 1 million people in the U.S. have received their first dose of the coronavirus vaccine as of Wednesday morning, a far cry from the federal government’s goal of inoculating 20 million Americans by the end of the year.
Now that two Covid-19 vaccines have been approved for emergency use, the biggest hurdle to the pandemic in the U.S. is getting the doses to the roughly 331 million Americans across the country. The Centers for Disease Control and Prevention said 1,008,025 shots had been administered as of Wednesday at 9 a.m. ET.
Breaking from its tentative recommendations on mask use thus far, the Centers for Disease Control and Prevention (CDC) said on Tuesday that using masks benefits wearers, which is a step beyond its previous declaration that said wearing masks would only protect those around them.
“Experimental and epidemiological data support community masking to reduce the spread” of the virus, the C.D.C. said in a document that details scientific evidence supporting mask use. “Individual benefit increases with increasing community mask use,” it said.
The unequivocal statements are a departure from the agency’s previous language, which suggested that “the latest science may convince” Americans to wear masks and that mask use could prevent an infected person from spreading the virus to others. “The main protection individuals gain from masking occurs when others in their communities also wear face coverings,” it said.
The agency also offered an economic argument, saying that increasing the proportion of people who wear masks by 15 percent could prevent the need for lockdowns and cut associated losses of up to $1 trillion, or about 5 percent of gross domestic product. The document also referred to a study of 124 Beijing households in which mask use significantly cut transmission of the virus, and an outbreak aboard the U.S.S. Theodore Roosevelt in which face coverings appeared to have reduced risk of infection by 70 percent.
The US Centers for Disease Control and Prevention (CDC) has updated its definition of a close contact with a Covid-19 patient to include multiple, brief exposures, director Dr. Robert Redfield said Wednesday.
The new definition includes exposures adding up to a total of 15 minutes spent six feet or closer to an infected person. Previously, the CDC defined a close contact as 15 minutes of continuous exposure to an infected individual.
The agency changed the definition after a report from Vermont of a corrections officer who became infected after several brief interactions with coronavirus-positive inmates – none of them lasting 15 minutes, but adding up over time.
“As we get more data and understand the science of Covid, we are going to incorporate that in our recommendations,” Redfield said at a news conference held at CDC headquarters in Atlanta. “Originally, contact that was considered to be high risk for potential exposure to Covid was someone within six feet for more than 15 minutes.”
Tiny droplets of saliva that are sprayed into the air when people speak may be sufficient to spread coronavirus, according to US government scientists who say the finding could help control the outbreak. Researchers at the US National Institutes of Health (NIH) in Maryland found that talking released thousands of fine droplets into the air that could pose a risk to others if the speaker were infected with the virus.
The scientists used laser imaging and high-speed videography to show how thousands of droplets that are too small to see with the naked eye are emitted in normal speech, even in short phrases such as “stay healthy”. The work is preliminary and has not been peer-reviewed or published, but in a report the scientists claim the findings may have “vital implications” for containing the pandemic.
“If speaking and oral fluid viral load proves to be a major mechanism of Sars-CoV-2 [the official name of the virus] transmission, wearing any kind of cloth mouth cover in public by every person, as well as strict adherence to social distancing and handwashing, could significantly decrease the transmission rate and thereby contain the pandemic until a vaccine becomes available,” the researchers write.
The results will fuel the ongoing debate over whether or not healthy people should wear face masks in public. Recent advice from the US Centers for Disease Control and Prevention called for members of the public to wear cloth face covers when they visit places where it is hard to maintain physical distancing, such as pharmacies and grocery stores.
But the US advice contrasts with that from the World Health Organization, which reviewed its stance on face masks last week. In updated guidance published on Monday it restated that there was no evidence wearing a mask in public prevented people from picking up respiratory infections such as Covid-19.
Airborne bacteria may see what looks like a comfy shag carpet on which to settle. But it’s a trap. Rice University scientists have transformed their laser-induced graphene (LIG) into self-sterilizing filters that grab pathogens out of the air and kill them with small pulses of electricity. The flexible filter developed by the Rice lab of chemist James Tour may be of special interest to hospitals. According to the Centers for Disease Control and Prevention, patients have a 1-in-31 chance of acquiring a potentially antibiotic-resistant infection during hospitalization. The device described in the American Chemical Society journal ACS Nano captures bacteria, fungi, fungi, prions, endotoxins and other biological contaminants carried by droplets, aerosols and particulate matter. The filter then prevents the microbes and other contaminants from proliferating by periodically heating up to 350 degrees Celsius (662 degrees Fahrenheit), enough to obliterate pathogens and their toxic byproducts. The filter requires little power, and heats and cools within seconds.
LIG is a conductive foam of pure, atomically thin carbon sheets synthesized through heating the surface of a common polyimide sheet with an industrial laser cutter. The process discovered by Tour’s lab in 2014 has led to a range of applications for electronics, triboelectric nanogenerators, composites, electrocatalysis and even art. Like all pure graphene, the foam conducts electricity. When electrified, Joule heating raises the filter’s temperature above 300 C, enough to not only kill trapped pathogens but also to decompose toxic byproducts that can feed new microorganisms and activate the human immune system. The researchers suggested a single, custom-fit LIG filter could be efficient enough to replace the two filter beds currently required by federal standards for hospital ventilation systems.
Seen in an electron microscope image, micron-scale sheets of graphene created at Rice University form a two-layer air filter that traps pathogens and then kills them with a modest burst of electricity
“So many patients become infected by bacteria and their metabolic products, which for example can result in sepsis while in the hospital,” Tour said. “We need more methods to combat the airborne transfer of not just bacteria but also their downstream products, which can cause severe reactions among patients.
“Some of these products, like endotoxins, need to be exposed to temperatures of 300 degrees Celsius in order to deactivate them,” a purpose served by the LIG filter, he added. “This could significantly lessen the transfer of bacteria-generated molecules between patients, and thereby lower the ultimate costs of patient stays and lessen sickness and death from these pathogens.”
The lab tested LIG filters with a commercial vacuum filtration system, pulling air through at a rate of 10 liters per minute for 90 hours, and found that Joule heating successfully sanitized the filters of all pathogens and byproducts. Incubating used filters for an additional 130 hours revealed no subsequent bacterial growth on the heated units, unlike control LIG filters that had not been heated.
“Bacteria culturing experiments performed on a membrane downstream from the LIG filter indicated that bacteria are unable to permeate the LIG filter,” said Rice sophomore John Li, co-lead author of the paper with postdoctoral researcher Michael Stanford. Stanford noted the sterilization feature “may reduce the frequency with which LIG filters would need to be replaced in comparison to traditional filters.” Tour suggested LIG air filters could also find their way into commercial aircraft.
Breast cancer is one of the most common cancers, and one of the leading causes of death in women globally. Breast cancer is a disease where cells located in the breast grow out of control. Although a majority of breast cancers are discovered in women at the age of 50 years or older, the disease can affect anyone, including men and younger women, according to the Centers for Disease Control and Prevention (CDC). Last year there were 9.6 million deaths and 18.1 million new cases of breast cancer diagnosed globally according to the latest report from the International Agency for Research on Cancer (IARC) released in September 2018.
In 2019 alone, the U.S. National Cancer Institute estimates that there will be 268,600 new female breast cancer cases and 41,760 fatalities. Earlier this month, researchers based in Switzerland published in Cell their study in using applied artificial intelligence (AI) machine learning to create a comprehensive tumor and immune atlas of breast cancer ecosystems that lays the foundation for innovative precision medicine and immunotherapy.
The study was led by professor Bernd Bodenmiller, Ph.D. at the Institute of Molecular Life Sciences at the University of Zurich in Switzerland. Bodenmiller is a recipient of the 2019 Friedrich Miescher Award, Switzerland’s highest distinction for outstanding achievements in biochemistry. His team worked in collaboration with the Systems Biology Group at IBM Research in Zurich led by María Rodríguez Martínez, Ph.D. with the shared goal to produce a foundation for more targeted breast cancer treatment through precision medicine.